Your Location:
Home >
Browse articles >
Clinical Effect of Runzaoling Combined with Iguratimod on Primary Sjögren's Syndrome
Clinical Effect of Runzaoling Combined with Iguratimod on Primary Sjögren's Syndrome
- “A study conducted by the Rheumatology and Immunology Department of the Second Affiliated Hospital of Guizhou University of Chinese Medicine found that the combination of alamod and traditional Chinese medicine Runzaoling compound has good clinical efficacy and safety in the treatment of primary Sjogren's syndrome.”
- Chinese Journal of Experimental Traditional Medical Formulae Vol. 30, Issue 2, Pages: 127-133(2024)
DOI: 10.13422/j.cnki.syfjx.20240398
Scan QR Code
AI Introduction
Full Text(HTML)
Figs( 1 ) Tabs( 5 )
References
Publication Info
Metrics
399
Views
454
Downloads
0
CSCD
Alert me when the article has been cited
Submit
Tools
- BibTeXDownload
- EndnoteDownload
- RefMan Download
- NoteExpressDownload
- NoteFirstDownload
Related Articles
Clinical Efficacy of Modified Yuejuwan in Treatment of Thyroid Cysts After Microwave Ablation
Clinical Efficacy of Zhuyuwan in Treatment of Hyperlipidemia with Syndrome of Phlegm Turbidity and Obstruction
Randomized, Open, Parallel Controlled, Multi-center Study for Efficacy and Safety of Lianhua Qingke Tablets in Treatment of Acute Bronchitis in Children with Syndrome of Phlegm-heat Obstructing Lung
Efficacy of Fuzheng Huayu Tablets for Treating Pulmonary Inflammation in COVID-19 Patients
Research Progress of Traditional Chinese Medicine in Improving Diabetic Retinopathy Based on Nrf2 Signaling Pathway
Related Author
YU Xiaojing
ZHOU Ying
XING Wei
LI Guolei
LOU Yingying
WANG Yashi
DONG Wenmin
YANG Lele
Related Institution
Graduate School of Hebei University of Chinese Medicine
The First Affiliated Hospital of Hebei University of Chinese Medicine/Hebei Provincial Hospital of Traditional Chinese Medicine
Hospital of Chengdu University of Traditional Chinese Medicine(TCM)
Chengdu University of TCM
Shijiazhuang Maternal and Child Health Care Hospital


